Offstream
news

---

Changes

1. Bahrain authorizes the emergency use of the Pfizer's anti-viral oral drug Paxlovid for adults aged above 18 years.
   2022-01-02 01:06:25 (First version)
2. Bahrain authorizes the emergency use of Pfizer's anti-viral oral drug Paxlovid for adults over the age of 18 years.
   (Current version)

---

Related

South Korea signs an agreement to buy an additional 400,000 doses of Pfizer's Paxlovid COVID-19 drug.
2022-01-5

The Belgian government finalizes an agreement to buy 20,000 courses of Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug.
2022-01-3

The Medicines and Healthcare products Regulatory Agency approves the use of Pfizer's anti-viral oral drug Paxlovid for high-risk patients.
2021-12-31

South Korea authorizes the emergency use of the anti-viral oral drug Paxlovid manufactured by Pfizer for high-risk patients over the age of 12 years, becoming the first drug to be approved for use in the country.
2021-12-27

The Israeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years, with delivery expected to begin in one week.
2021-12-25

The Food and Drug Administration grants emergency use authorization for Pfizer's antiviral COVID-19 oral pill named Paxlovid for at-risk people over the age of 12 years, becoming the first at-home oral treatment to be approved by the FDA.
2021-12-22

The final results of a trial of Paxlovid conducted by Pfizer shows 89% cut of risk of hospitalization and death in high-risk patients and is likely to work against the Omicron variant.
2021-12-14

Pfizer and the Medicines Patent Pool sign a global licensing agreement that will allow Pfizer's experimental COVID-19 oral drug Paxlovid to be manufactured under a royalty-free license in 95 low and middle-income countries.
2021-11-16

A late-stage trial of the oral drug Paxlovid conducted by Pfizer shows an 89% reduction in hospitalizations and deaths.
2021-11-5

Bahrain grants emergency use authorization for the COVID-19 vaccine made by Pfizer and BioNTech, becoming the second country after the United Kingdom to approve the vaccine.
2020-12-4